World’s first single shot vaccine for coronavirus

The Food and Drug Administration (FDA) of United States of America has approved third vaccine for emergency use to control pandemic virus in the country. 

There is no surprise in accepting new vaccine by U.S. FDA grants emergency use authorization for Johnson & Johnson’s covid-19 vaccine. It has approved in the country when there is steep decline in coronavirus cases and people in the country are waiting for vaccination.

So far more than half-million people killed in U.S. because of pandemic virus. It is single shot is effective in preventing severe covid-19. Johnson & Johnson vaccine is effective against newer variants of the virus. When Moderna and Pfizer are using more than single jab in vaccination schedule Johnson & Johnson vaccine is use for just single shot. The vaccine efficacy against coronavirus was 85.9% in the U.S., 81.7% in South Africa and 87.6% in Brazil. Johnson & Johnson has pledged to provide the United States with 100 million doses by the end of June.

Two shot of vaccines made by Pfizer-BioNTech and Moderna of 600 million doses to arrive by the end of July. But health officials may perceive that Johnson & Johnson first shot as an inferior option. Johnson & Johnson’s single dose vaccine will allow states to rapidly increase the number of people who have been fully inoculated. 40K people across all the states participated for Johnson & Johnson’s vaccine trial. The vaccine can store three months at standard refrigeration temperatures which can’s possible in Moderna and Pfizer. Johnson & Johnson vaccine can easier to transport that can’t possible to other vaccines.